Serum Collagen Markers and Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets · 01.07.2012 · 12 (1) · 51-55
DOI: 10.2174/187152912801823147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular & Hematological Disorders-Drug Targets, erschienen am 01.07.2012. Verfasst von P J Lijnen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hypertension and Cardiovascular Rehabilitation Unit, Department Cardiovascular Sciences, Katholieke Universiteit Leuven, Belgium. paul.lijnen@med.kul…. Die Arbeit wurde bisher 35-mal zitiert (Crossref).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Increased myocardial collagen accumulation is present in almost every cardiac disease and plays an important role in the reduced heart function. N-terminal and C-terminal propeptides of collagen type I and III, the two major collagen types in the heart, can be assayed in serum.These propeptides (PINP, PIIINP, PICP, ICTP) reflect collagen synthesis and degradation. The use of these serum collagen biomarkers as prognostic or diagnostic tools is an area of active investigation. In this review article these studies will be discussed as well as the limitations of these serum biomarkers as indicators of cardiac fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hypertension and Cardiovascular Rehabilitation Unit, Department Cardiovascular Sciences, Katholieke Universiteit Leuven, Belgium. paul.lijnen@med.kuleuven.be
Zitieren
APA
Lijnen, P. J., Maharani, T., Finahari, N., & Prihadi, J. S. (2012). Serum Collagen Markers and Heart Failure. Cardiovascular & Hematological Disorders-Drug Targets, 12(1), 51-55. https://doi.org/10.2174/187152912801823147
Vancouver
Lijnen PJ, Maharani T, Finahari N, Prihadi JS. Serum Collagen Markers and Heart Failure. Cardiovascular & Hematological Disorders-Drug Targets. 2012;12(1):51-55. doi:10.2174/187152912801823147
BibTeX
@article{Lijnen2012,
author = {Lijnen, P J and Maharani, T and Finahari, N and Prihadi, J S},
title = {Serum Collagen Markers and Heart Failure},
journal = {Cardiovascular & Hematological Disorders-Drug Targets},
year = {2012},
volume = {12},
number = {1},
pages = {51--55},
doi = {10.2174/187152912801823147}
}
EUVIMED